Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

IGF-1 vs Tesamorelin

IGF-1 and Tesamorelin are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Hormonal & EndocrineMetabolic
Class70-residue single-chain protein (native IGF-1), three disulfide bondsFull-length 44-residue GHRH analogue with trans-3-hexenoic acid modification
Molecular weight7648.7 g/mol5135.0 g/mol
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥99%≥99%
Research areasHormonal & Endocrine, Musculoskeletal, MetabolicHormonal & Endocrine, Metabolic
Primary diluentDilute acetic acid for initial dissolutionBacteriostatic water (0.9% benzyl alcohol)
Working windowShort — days rather than weeks — and shorter still with repeated handling.Commonly worked with for 2–3 weeks at 2–8 °C.
Lead degradation routeMisfolding and irreversible denaturation — the dominant failure mode.Aggregation at air–liquid interfaces from agitation — the practical failure mode for longer chains.
Freeze–thawPoorly tolerant. Repeated freeze-thaw denatures the folded structure permanently, so aliquot for single use rather than relying on any freeze tolerance.Do not freeze reconstituted material. At this chain length, interfacial aggregation during freezing is a real risk.
Light sensitivityNo specific light requirement beyond normal practice.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: IGF-1 is 70-residue single-chain protein (native igf-1), three disulfide bonds, while Tesamorelin is full-length 44-residue ghrh analogue with trans-3-hexenoic acid modification — different molecular classes with different handling consequences; they call for different primary diluents (dilute acetic acid for initial dissolution versus bacteriostatic water (0.9% benzyl alcohol)); their leading degradation routes differ (misfolding and irreversible denaturation for IGF-1, aggregation at air–liquid interfaces from agitation for Tesamorelin), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

IGF-1 — origin

IGF-1 is the native insulin-like growth factor — a folded 70-amino-acid protein stabilised by three internal disulfide bonds. It is the downstream messenger produced after growth hormone acts, and it is handled as a protein rather than a short peptide. This is the native sequence, distinct from the long-acting LR3 analogue.

Tesamorelin — origin

Tesamorelin is the complete 44-amino-acid sequence of human growth hormone-releasing hormone with a trans-3-hexenoic acid group attached at the N-terminus. That modification exists for one reason: native GHRH is cleaved almost immediately by dipeptidyl peptidase-4 at the N-terminal end, and the hexenoyl group blocks that cleavage.

IGF-1 research themes

IGF-1 receptor signalling

Studied as the native ligand for the IGF-1 receptor and its downstream proliferation and survival pathways.

Satellite cell activation

Examined in muscle research models for its role in satellite-cell behaviour and anabolic signalling.

Native versus analogue

Compared with IGF-1 LR3, whose reduced binding-protein affinity gives a longer active window — a contrast studied directly in the literature.

Tesamorelin research themes

GHRH receptor agonism

Full-length GHRH activity with DPP-4 resistance conferred by the N-terminal modification.

Visceral adipose tissue

The most distinctive endpoint in its research literature.

GH pulsatility

Studied for effects on endogenous GH secretion patterns rather than direct GH substitution.

Metabolic parameters

Investigated alongside body-composition endpoints in metabolic research.

IGF-1 handling

  • Dissolve first in dilute acetic acid, then dilute into the working buffer — never expect plain water to take it up fully.
  • Use a carrier protein and low-bind labware to prevent adsorptive loss.
  • Aliquot for single use; do not re-freeze reconstituted protein.

Tesamorelin handling

  • Allow several minutes for dissolution; do not accelerate with agitation or heat.
  • Swirl gently — long chains aggregate at interfaces.
  • Do not freeze reconstituted solution.

Both third-party tested

Every Popular Peptides batch of IGF-1 and Tesamorelin is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

IGF-1 reference

Full IGF-1 reference IGF-1 storage IGF-1 reconstitution IGF-1 calculatorIGF-1 product details

Tesamorelin reference

Full Tesamorelin reference Tesamorelin storage Tesamorelin reconstitution Tesamorelin calculatorTesamorelin product details

Related comparisons

5-Amino-1MQ vs IGF-15-Amino-1MQ vs TesamorelinCJC-1295 (No DAC) vs IGF-1CJC-1295 (No DAC) vs TesamorelinCJC-1295 + Ipamorelin vs IGF-1CJC-1295 + Ipamorelin vs TesamorelinIGF-1 LR3 vs TesamorelinIGF-1 vs IGF-1 LR3

IGF-1 and Tesamorelin are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.